The TP53 mutations are also associated with vascular invasion (p = 0.0029) and shorter recurrence-free survival in HCC patients after liver transplantation when associated with an absence of CTNNB1 mutation (p = 0.009) [113]. Here, CTNNB1 is linked to hepatocellular carcinoma.